1. Home
  2. MRBK vs CCCC Comparison

MRBK vs CCCC Comparison

Compare MRBK & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRBK
  • CCCC
  • Stock Information
  • Founded
  • MRBK 2004
  • CCCC 2015
  • Country
  • MRBK United States
  • CCCC United States
  • Employees
  • MRBK N/A
  • CCCC N/A
  • Industry
  • MRBK Major Banks
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRBK Finance
  • CCCC Health Care
  • Exchange
  • MRBK Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • MRBK 162.3M
  • CCCC 160.1M
  • IPO Year
  • MRBK 2017
  • CCCC 2020
  • Fundamental
  • Price
  • MRBK $14.31
  • CCCC $2.46
  • Analyst Decision
  • MRBK Buy
  • CCCC Strong Buy
  • Analyst Count
  • MRBK 2
  • CCCC 4
  • Target Price
  • MRBK $17.50
  • CCCC $8.50
  • AVG Volume (30 Days)
  • MRBK 55.5K
  • CCCC 2.4M
  • Earning Date
  • MRBK 10-23-2025
  • CCCC 11-03-2025
  • Dividend Yield
  • MRBK 3.39%
  • CCCC N/A
  • EPS Growth
  • MRBK 75.95
  • CCCC N/A
  • EPS
  • MRBK 1.77
  • CCCC N/A
  • Revenue
  • MRBK $109,758,000.00
  • CCCC $34,240,000.00
  • Revenue This Year
  • MRBK $25.14
  • CCCC N/A
  • Revenue Next Year
  • MRBK $8.08
  • CCCC N/A
  • P/E Ratio
  • MRBK $8.10
  • CCCC N/A
  • Revenue Growth
  • MRBK 18.84
  • CCCC 16.55
  • 52 Week Low
  • MRBK $11.16
  • CCCC $1.09
  • 52 Week High
  • MRBK $17.33
  • CCCC $6.52
  • Technical
  • Relative Strength Index (RSI)
  • MRBK 41.96
  • CCCC 51.93
  • Support Level
  • MRBK $14.27
  • CCCC $2.45
  • Resistance Level
  • MRBK $15.15
  • CCCC $2.79
  • Average True Range (ATR)
  • MRBK 0.54
  • CCCC 0.22
  • MACD
  • MRBK -0.00
  • CCCC 0.03
  • Stochastic Oscillator
  • MRBK 28.28
  • CCCC 60.24

About MRBK Meridian Corporation

Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: